Luca Magnani

28PUBLICATIONS

275CO-AUTHORS

Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (28)

Sort by Publication Date:

|Jul 10, 2026

Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Apr 29, 2026

GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Dec 09, 2025

Chemically modified CRISPR-Cas9 enables targeting of individual G-quadruplex and i-motif structures, revealing ligand-dependent transcriptional perturbation.

Sabrina Pia Nuccio, Enrico Cadoni, Roxani Nikoloudaki

|Jun 11, 2025

Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm.

Erica A Oliveira, Salvatore Milite, Javier Fernandez-Mateos

|Oct 02, 2024

Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer.

Carolina Gemma, Chun-Fui Lai, Anup K Singh

|May 16, 2024

A Functional Survey of the Regulatory Landscape of Estrogen Receptor-Positive Breast Cancer Evolution.

Iros Barozzi, Neil Slaven, Eleonora Canale

Pageof 5

Frequent Collaborators

Andrea Sottoriva

George D Cresswell

Timon Heide

Leandro Castellano

Trevor A Graham

Simak Ali

Inmaculada Spiteri

Giancarlo Pruneri

Emre Sofyali

Georgios Vlachogiannis

Frequent Collaborators

Andrea Sottoriva

George D Cresswell

Timon Heide

Leandro Castellano